A rational approach to vitamin D supplementation

Nutrition

Volumn 28, Issue 11-12, 2012, Pages 1204-1205

  Boullata, Joseph I ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; COLECALCIFEROL; ERGOCALCIFEROL; VITAMIN D;

ARTICLE; CALCIUM URINE LEVEL; CYSTIC FIBROSIS; DOSAGE SCHEDULE COMPARISON; DRUG DOSE COMPARISON; HUMAN; HYPERCALCEMIA; LOADING DRUG DOSE; OSTEOMALACIA; OSTEOPOROSIS; PRIORITY JOURNAL; SIDE EFFECT; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

ADULT; CHOLECALCIFEROL; DIETARY SUPPLEMENTS; ERGOCALCIFEROLS; EVIDENCE-BASED MEDICINE; FOOD, FORTIFIED; HEALTH PROMOTION; HUMANS; PRACTICE GUIDELINES AS TOPIC; SEVERITY OF ILLNESS INDEX; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84867165350     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2012.08.002     Document Type: Article

References (23)

1. Looker A.C., Pfeiffer C.M., Lacher D.A., Schleicher R.L., Picciano M.F., Yetley E.A. Serum 25-hydroxyvitamin D status of the U.S. population: 1988-1994 compared with 2000-2004. Am J Clin Nutr 2008, 88:1519-1527.
2. Hyppönen E., Power C. Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr 2007, 85:860-868.
3. Leidig-Bruckner G., Roth H.J., Bruckner T., Lorenz A., Raue F., Frank-Raue K. Are commonly recommended dosages for vitamin D supplementation too low? Vitamin D status and effects of supplementation on serum 25-hydroxyvitamin D levels-an observational study during clinical practice conditions. Osteoporos Int 2011, 22:231-240.
4. Whiting S.J., Langlois K.A., Vatanparast H., Greene-Finestone L.S. The vitamin D status of Canadians relative to the 2011 Dietary Reference Intakes: an examination in children and adults with and without supplement use. Am J Clin Nutr 2011, 94:128-135.
5. Boullata J.I. Vitamin D supplementation: a pharmacologic perspective. Curr Opin Clin Nutr Metab Care 2010, 13:677-684.
6. Dietary reference intakes for calcium and vitamin D 2011, Institute of Medicine (IOM), National Academy Press, Washington, DC.
7. Holick M.F., Binkley N.C., Bischoff-Ferrari H.A., Gordon C.M., Hanley D.A., Heaney R.P., et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011, 96:1911-1930.
8. Looker A.C., Johnson C.L., Lacher D.A., Pfeiffer C.M., Schleicher R.L., Sempos C.T. Vitamin D status: United States, 2001-2006. NCHS Data Brief March 2011, 59.
9. West N.E., Lechtzin N., Merlo C.A., Turowski J.B., Davis M.E., Ramsay M.Z., et al. Appropriate goal level for 25-hydroxyvitamin D in cystic fibrosis. Chest 2011, 140:469-474.
10. Khazai N.B., Judd S.E., Jeng L., Wolfenden L.L., Stecenko A., Ziegler T.R., Tangpricha V. Treatment and prevention of vitamin D deficiency in cystic fibrosis patients: comparative efficacy of ergocalciferol, cholecalciferol, and UV light. J Clin Endocrinol Metab 2009, 94:2037-2043.
11. Viard J.-P., Souberbielle J.-C., Kirk O., Reekie J., Knysz B., Losso M., et al. Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study. AIDS 2011, 25:1305-1315.
12. Weinstock-Guttman B., Zivadinov R., Qu J., Cookfair D., Duan X., Bang E., et al. Vitamin D metabolites are associated with clinical and MRI outcomes in multiple sclerosis patients. J Neurol Neurosurg Psychiatry 2011, 82:189-195.
13. Gupta K., Warner J.T. Inappropriate and inconsistent modalities of treatment of vitamin D deficiency in children. Arch Dis Child 2011, 96:787.
14. 3 and weekly alendronate 70 mg in men and women with osteoporosis. Ann Pharmacother 2011, 45:561-568.
15. Heaney R.P., Holick M.F. Why the IOM recommendations for vitamin D are deficient. J Bone Miner Res 2011, 26:455-457.
16. Papaioannou A., Kennedy C.C., Giangregorio L., Ioannidis G., Pritchard J., Hanley D.A., et al. A randomized controlled trial of vitamin D dosing strategies after acute hip fracture: no advantage of loading doses over daily supplementation. BMC Musculoskelet Disord 2011, 12:135.
17. Binkley N., Gemar D., Engelke J., Gangnon R., Ramamurthy R., Krueger D., Drezner M.K. Evaluation of ergocalciferol or cholecalciferol dosing, 1,600 IU daily or 50,000 IU monthly in older adults. J Clin Endocrinol Metab 2011, 96:981-988.
18. Kimball S.M., Burton J.M., O'Connor P.G., Vieth R. Urinary calcium response to high dose vitamin D3 with calcium supplementation in patients with multiple sclerosis. Clin Biochem 2011, 44:930-932.
19. 3 supplementation in the elderly. Osteoporos Int 2009, 20:1407-1415.
20. Zia A.A., Komolafe B.O., Moten M., Ahokas R.A., McGee J.E., Rosenberg W., et al. Supplemental vitamin D and calcium in the management of African Americans with heart failure having hypovitaminosis D. Am J Med Sci 2011, 341:113-118.
21. Holick M.F., Biancuzzo R.M., Chen T.C., Klein E.K., Young A., Bibuld D., et al. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab 2008, 93:677-681.
22. 2 in humans. J Clin Endocrinol Metab 2011, 96:E447-E452.
23. DEQAS. Vitamin D External Quality Assessment Scheme. Available at: Accessed January 2012. http://www.deqas.org.